SH.Consulting
Market Snapshot
Market

Market

A daily market brief, published each morning. Markets, stocks, industry, economy, global, and policy — sorted by category.

Stocks·2026-07-10

SK Hynix Prices ADR; Defense and Biotech Stocks Diverge

SK Hynix priced its Nasdaq ADR at $149, roughly a 3.1% premium to Thursday's Korean market close. The stock jumped about 3% in after-hours trading immediately following the announcement. Institutional demand reached about seven times the offering, drawing over $2 billion in orders from more than 500 institutions, with the top 25 accounts taking 67% of the allocation. Each ADR represents 10 common shares, and ADRs cannot be directly exchanged for local shares. The underlying stock traded up 1-2% around 2.22 million won. A heartwarming story about Samsung Electronics Chairman Lee Jae-yong also circulated: after a cleaning worker who had served at Samsung's Seocho headquarters for over two decades passed away, Lee reportedly cancelled his schedule to pay respects alone at the funeral, drawing praise for a shift in corporate culture. Defense stocks were a focal point in a discussion with LS Securities analyst Lee Jae-kwang. Hanwha Aerospace and Hyundai Rotem already show solid earnings and margins, making their forward-looking valuations look comparatively low, while LIG Nex1 and Korea Aerospace Industries (KAI) appear undervalued when measured against order backlog relative to enterprise value. He cautioned against over-reading quarterly results in a project-based industry, advising investors instead to track order-backlog trends. Biotech names diverged sharply. Peptron plunged to the daily limit down after its CEO suggested at an industry event that the compound behind its Eli Lilly collaboration wasn't the widely expected tirzepatide. HLB also hit the limit down after receiving its third FDA complete-response letter for gastric cancer drug rivoceranib. Still, news that ProteinaCore signed a follow-on licensing deal with Samsung Biologics limited contagion to other biotech names, and bargain-hunting emerged after the Kosdaq briefly dipped into the 700s, helping the broader sector hold up relatively well.

Read more →
Stocks·2026-07-09

SK Hynix ADR oversubscribed sevenfold ahead of Nasdaq debut

SK Hynix's US depositary receipt offering drew subscriptions of more than seven times the offered amount, according to Bloomberg. Cornerstone investors alone accounted for 25% of the offering, and demand exceeded supply even after bookbuilding closed early. Listing is set for July 10 (Friday night Korea time), with a reference price of $158, roughly 2.3 million won. Long-only funds, tech-focused funds and sovereign wealth funds were among the diverse institutional buyers, and Chairman Chey Tae-won is scheduled to give an interview at Nasdaq on the 12th. The initial listing covers about 17.79 million shares, or roughly 2.5% of shares outstanding, but the registration ceiling filed with the US SEC allows for up to ten times that amount, or 25%. Hosts interpreted this as opening the door for continued outflow of domestically traded shares into ADR custody if demand persists, which could tighten local float and support the Korea-listed share price. This interpretation was read as a signal that investors expect continued share price appreciation for SK Hynix. Hosts emphasized that beyond short-term supply dynamics, the underlying institutional conviction in the semiconductor cycle is the more important signal.

Read more →
Stocks·2026-07-08

Samsung Posts Record Profit, Yet Target Prices Keep Getting Cut

Samsung Electronics reported operating profit of roughly 57 trillion won in the first quarter and about 89 trillion won in the second — both record highs for consecutive quarters. Even so, the share price fell sharply, with some arguing the results were 'already priced in' or 'a one-off that won't last.' The hosts countered that back at the start of the year, nobody had predicted Samsung would earn 89 trillion won just six months later. Kiwoom Securities became the first Korean brokerage to cut its Samsung target price, lowering it from 430,000 won to 390,000 won. The rationale cited slowing second-half EPS growth, fading expectations for HBM4 market-share gains, and rising competition from Chinese memory makers — all of which could widen share-price volatility. The hosts conceded the logic itself was reasonable — triple-digit-percentage profit growth every quarter was never going to be sustainable forever. But they drew a line between 'fact' and 'truth': if a child brings home a perfect score, a parent can't reasonably demand 120 points next time before handing over allowance. Likewise, as long as Samsung keeps posting roughly 100 to 112 trillion won in quarterly operating profit through the third and fourth quarters, the stock still looks cheap at today's valuation. On the very same day, Hyundai Motor Securities analyst Roh Geun-chang kept his target price at 440,000 won in a report humorously titled 'earning too much and rising too much is the only original sin,' arguing that the ongoing AI-transition supercycle should keep profits at this elevated level. The market, in effect, is split between a 'growth-deceleration' camp and a 'profit-durability' camp. Trading action that day reflected the split — SK Hynix jumped more than 3%, while Samsung Electronics slipped about 2%, barely holding the 290,000-won line.

Read more →